<- Go Home
Vetoquinol SA
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Market Cap
EUR 861.1M
Volume
4.0K
Cash and Equivalents
EUR 181.5M
EBITDA
EUR 102.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 308.2M
Profit Margin
57.89%
52 Week High
EUR 96.00
52 Week Low
EUR 63.60
Dividend
N/A
Price / Book Value
1.51
Price / Earnings
14.32
Price / Tangible Book Value
2.38
Enterprise Value
EUR 697.4M
Enterprise Value / EBITDA
6.41
Operating Income
EUR 78.4M
Return on Equity
10.79%
Return on Assets
6.84
Cash and Short Term Investments
EUR 181.5M
Debt
EUR 17.7M
Equity
EUR 567.5M
Revenue
EUR 532.4M
Unlevered FCF
EUR 44.3M
Sector
Pharmaceuticals
Category
N/A